Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

NCA21114 Tecan Freedom EVO

  • First published: 04 August 2022
  • Last modified: 04 August 2022
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-035872
Published by:
University Of Edinburgh
Authority ID:
AA21242
Publication date:
04 August 2022
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The Tecan Freedom EVO will allow accurate processing of the new generation arrays, these have smaller beads that allows higher genomic content and increased samples per bead chip. Improvements in the workflow decreases processing time from 3 days to 2 days therefore allowing higher throughput. Improvements in reagents give better signal to noise ratio and, importantly, removes the need for formamide so safer for technicians and the environment. Genotyping and methylation arrays continue to be a popular and economical method for genomic investigation with many thousands of samples ran each year.

The Genetics Core, Edinburgh Clinical Research Facility, has been running Illumina arrays since 2005. As a core facility it provides equitable access to researchers at all stages of their career on a simple cost-recovery model.

The Tecan Freedom EVO will be used to process the new arrays as released. The first two confirmed arrays are:

Global Clinical Research Array – a 24-sample bead chip with 1.3M markers

Global Screening Array (v4) – an updated version of the GSA v3 but allowing 48 samples to be processed, increased from 24, so allowing higher throughput and reduced processing costs.

This will support new and ongoing studies such as GenOMICC (Prof Baillie) where over 22k covid19 patient samples have been genotyped using the GSA (Nature 2021) and Generation Scotland (Prof Sudlow) as they collect and genotype a further 20k samples, as well as many small to medium sized projects across Edinburgh and the UK

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

University Of Edinburgh

Charles Stewart House, 9-16 Chambers Street

Edinburgh

EH1 1HT

UK

E-mail: e.silvester@ed.ac.uk

NUTS: UKM75

Internet address(es)

Main address: http://www.ed.ac.uk/schools-departments/procurement/supplying

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA00107

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Education

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

NCA21114 Tecan Freedom EVO

Reference number: NCA21114

II.1.2) Main CPV code

42997300

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Device to replace the current automated platform and will allow the processing of the new generation of genotyping arrays.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 114 008.00  GBP

II.2) Description

II.2.2) Additional CPV code(s)

42997300

II.2.3) Place of performance

NUTS code:

UKM75

II.2.4) Description of the procurement

The Tecan Freedom EVO will allow accurate processing of the new generation arrays, these have smaller beads that allows higher genomic content and increased samples per bead chip. Improvements in the workflow decreases processing time from 3 days to 2 days therefore allowing higher throughput. Improvements in reagents give better signal to noise ratio and, importantly, removes the need for formamide so safer for technicians and the environment. Genotyping and methylation arrays continue to be a popular and economical method for genomic investigation with many thousands of samples ran each year.

The Genetics Core, Edinburgh Clinical Research Facility, has been running Illumina arrays since 2005. As a core facility it provides equitable access to researchers at all stages of their career on a simple cost-recovery model.

The Tecan Freedom EVO will be used to process the new arrays as released. The first two confirmed arrays are:

Global Clinical Research Array – a 24-sample bead chip with 1.3M markers

Global Screening Array (v4) – an updated version of the GSA v3 but allowing 48 samples to be processed, increased from 24, so allowing higher throughput and reduced processing costs.

This will support new and ongoing studies such as GenOMICC (Prof Baillie) where over 22k covid19 patient samples have been genotyped using the GSA (Nature 2021) and Generation Scotland (Prof Sudlow) as they collect and genotype a further 20k samples, as well as many small to medium sized projects across Edinburgh and the UK

II.2.5) Award criteria

Quality criterion: Quality / Weighting: 50

Price / Weighting:  50

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons

Explanation

Business Need Requirements

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract

Contract No: NCA21028

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/02/2022

V.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 0

Number of tenders received from tenderers from non-EU Member States: 1

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Illumina

Illumina Centre, 19 Granta Park

Cambridge

CB21 6DF

UK

Telephone: +44 7442855826

NUTS: UK

Internet address(es)

URL: https://www.illumina.com/

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 187 600.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

(SC Ref:698677)

VI.4) Procedures for review

VI.4.1) Review body

Edinburgh Sheriff Court and Justice of the Peace Court

Edinburgh

EH1 1LB

UK

VI.5) Date of dispatch of this notice

03/08/2022

Coding

Commodity categories

ID Title Parent category
42997300 Industrial robots Pipeline machinery

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
e.silvester@ed.ac.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.